Cision PR Newswire

Clover Announces Positive Phase 2 Clinical Data for RSV + hMPV ± PIV3 Respiratory Combination Vaccine Candidates in Older Adults

-- Positive Phase 2 (Australia) results strengthen potential best-in-class profile of RSV+hMPV±PIV3 combination vaccines, with the potential differentiated ability to re-vaccinate individuals previously receiving approved RSV vaccines to restore and broaden protection -- -- Robust neutralizing antibody responses across RSV, hMPV and PIV3 in Phase 2 recapitulates Phase...

Fosun Pharma Announces H-Share Repurchase Plan of Up to HK$ 1 Billion

SHANGHAI, Sept. 7, 2026 /PRNewswire/ -- Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ("Fosun Pharma", stock...

FDI World Dental Federation launches Generation Smile, the oral health movement for all

Generation Smile is a generation unlike any other. It isn't defined by the year...

China Xplained | The China Squeeze, or the China Opportunity?

GUANGZHOU, China, Sept. 6, 2026 /PRNewswire/ -- This is a news report from South: ...

China Science Fiction Convention Concludes with Insightful “Sci-Fi+” Forums Exploring Future Frontiers

BEIJING,  April 2, 2025 /PRNewswire/ -- The China Science Fiction Convention 2025 (CSFC 2025) culminated with four high-profile thematic forums—"Sci-Fi + Talent," "Sci-Fi +...

SUEZ and Sonadezi Forge Strategic Partnership to Provide Integrated Environmental Solutions for Industrial Park in Vietnam

HO CHI MINH CITY, April 2, 2025 /PRNewswire/ -- SUEZ signed a joint venture agreement with Sonadezi, a state-owned company who has developed and currently manages 11...

GCL Technology (Stock code: 3800.HK) Fully Exits Xinjiang Rod-Polysilicon Investment, Redirecting Focus on FBR Granular-Polysilicon Production

HONG KONG, April 2, 2025 /PRNewswire/ -- On March 28th, GCL Technology (Stock code: 3800.HK)  released its 2024 annual financial report, revealing that the company...